Publications

  • News for the Week of December 17, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: Vote on Toronto Star Op-ed and Tell Readers Why Pharmacists Should be Allowed to Prescribe for Common Ailments
    • ICYMI: Ministry Announcement Brings Good News for Pharmacy
    • Last Call to Submit Presentation Proposals for 2020 OPA Conference

    • Managing Your Pharmacy: The Business Essentials
    • Collaborating with Family Physicians: The Rx For Success
    • Essential Cannabis Knowledge for Pharmacy Technicians Program

    • Ask the Customer Experience Administration Team
    • Dell’s Biggest Boxing Week Ever
    • OPA Membership Deadline is December 31, 2019

    • Professional Liability Insurance: "Claims Made" Versus "Occurrence"

    • DDD Notice No. 19191 posted December 16, 2019 Notice: Policy for Pharmacy Payments under the Long-Term Care Home Capitation Funding Model, 2020
    • DDD Notice No. 19190 posted December 16, 2019 Notice: Amendments to Ontario Regulation 201/96 made under the Ontario Drug Benefit Act to Improve the Value of Pharmacy Payments
    • DDD Notice No. 19189 posted December 16, 2019 Notice: Amendments to Ontario Regulation 201/96 made under the Ontario Drug Benefit Act and Regulation 935 made under the Drug Interchangeability and Dispensing Fee Act
    • DDD Notice No. 19188 posted December 13, 2019 ODB FORMULARY – EDITION NO. 43, Summary of Changes – December 2019
    • DDD Notice No. 19185 posted December 12, 2019 Prescription Forgery Alert
    • DDD Notice No. 19184 posted December 11, 2019 Prescription Forgery Alert

  • News for the Week of December 10, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Ontario College of Pharmacists Makes Headway on Minor Ailments
    • Updated FAQs on "Improving the Value of Pharmacy Payments"
    • Ontario Deprescribing in Long-Term Care Forum June 2019 Report
    • Call for Presentations for OPA Annual Conference

    • Applying NAPRA’s Non-Sterile Compounding Standards into Practice
    • Selling What You Can Do for Your Clients Program
    • Medical Devices Training for Pharmacy Technicians

    • Ask the Practice Support Network
    • OPA Membership Deadline is December 31, 2019

    • Why Buy Life Insurance?

    • Drug Shortage / Supply Health System Alert: Tamoxifen

    • DDD Notice No. 19183 posted December 10, 2019 Prescription Forgery Alert
    • DDD Notice No. 19182 posted December 10, 2019 Prescription Forgery Alert
    • DDD Notice No.19178 posted December 6, 2019 Prescription Forgery Alert
    • DDD Notice No.19177 posted December 6, 2019 Prescription Forgery Alert

    • Health Canada evaluating NDMA in metformin drugs

  • News for the Week of December 3, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Advocacy in Action – OPA in the Trenches
    • UofT Leslie Dan Faculty of Pharmacy Career Fair
    • Call for Presentations for OPA Annual Conference
    • Health Canada Guidance Document: Handling and Destruction of Post-consumer Returns Containing Controlled Substances

    • Managing Your Pharmacy: The Business Essentials
    • Collaborating with Family Physicians: The Rx For Success

    • Last Week Before 2020 Early Bird Deadline Draw
    • Ask the Customer Experience and Administration Team

    • Simultaneously Practising in Ontario and One or Two Other Provinces

    • DDD Notice No. 19176 posted November 29, 2019 Prescription Forgery Alert

    • Important Safety Update on XELJANZ / XELJANZ XR (tofacitinib) – Risk of Thrombosis - Pfizer Canada ULC
    • Nitrosamine - Information Update

  • News for the week of November 26, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Attention Pharmacy Owners: Submit Responses to Reducing the Administrative Burden to Drug Manufacturers and Pharmacies - Deadline Wednesday, November 27, 2019
    • Ontario College of Pharmacists' Council Approves First Set of Regulatory Amendments to Expand Scope
    • Call for Presentations for OPA Annual Conference
    • Vaccines4Life Launches "Identifying Barriers to Adult Influenza Vaccination in Canada" Report
    • OPA Student Open Forum
    • University of Toronto Lunch and Learn
    • A Guide to Traveling with Medication

    • Applying NAPRA’s Non-Sterile Compounding Standards into Practice
    • Essential Cannabis Knowledge for Pharmacy Technicians Program
    • Selling What You Can Do for Your Clients Program

    • Ask the Practice Support Network
    • 2020 Early Bird Membership Draw

    • Planning to Retire or Move to Part B of the Register?

    • DDD Notice No. 19175 posted November 22, 2019 ODB Formulary – Edition No. 43, Summary of Changes – November 2019

    • Drug Shortage / Supply Health System Alert: PrTOMUDEX® (Raltitrexed disodium for Injection), 2mg / Vial
    • Drug Shortage / Supply Health System Alert: Tamoxifen Supply Status

    • Ayurvedic products - Advisory

  • News for the week of November 19, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Antibiotic Awareness Week: November 18-24
    • OPA Student Open Forum
    • OPA at OnPharmUnited Annual Conference
    • Green Shield Canada’s Pharmacist Deprescribing Program

    • Billing 101: Ontario Drug Benefit (ODB) and Third-Party Insurance
    • FREE! Take-Home Naloxone Program at Community Pharmacies
    • FREE! Opioid Addiction and Substitution Therapy Free Live Webinar Series
    • OPA Continuing Education Co-ordinators Share Best Practices

    • Ask the Customer Experience and Administration Team
    • ICYMI: Don't Forget to Renew Your PLI
    • Special member rates on Toronto area attractions

    • Are you a part of a Local Area Network (LAN) or Wide Area Network (WAN)?

    • DDD Notice No. 19172 posted November 19, 2019 Prescription Forgery Alert
    • DDD Notice No. 19171 posted November 18, 2019 Prescription Forgery Alert
    • DDD Notice No. 19170 posted November 18, 2019 Prescription Forgery Alert
    • DDD Notice No. 19168 posted November 13, 2019 Prescription Forgery Alert
    • DDD Notice No. 19167 posted November 13, 2019 Prescription Forgery Alert

    • Drug Shortage / Supply Health System Alert: Fludarabine 25mg/ml - 2ml vial

  • News for the week of November 12, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: OPA 2020 Membership Launch - Are You With Us?
    • ICYMI: OPA Profession Update
    • The Canadian Foundation for Pharmacy Pillar of Pharmacy Award: Honouring Sherry Peister
    • Important Information About DIRC in 2020
    • World Diabetes Day is November 14
    • OPA Call for Presentations Coming Soon
    • Reminder: Register for U of T Leslie Dan Faculty of Pharmacy Class of 8T9 30th year reunion

    • How to Add Value to The Pharmacy Business as A Pharmacy Technician
    • FREE! Opioid Addictions and Substitution Therapy Online Modules
    • Paid Consultations - Opportunities and Timesavers

    • Ask the Practice Support Network

    • Professional Liability Insurance Claims Reporting

    • DDD Notice No. 19165 posted November 7, 2019 Prescription Forgery Alert

  • News for the week of November 5, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Updated: Frequently Asked Questions on Improving the Value of Pharmacy Payments

    • FAQs and a New Drugs Update on Contraception and Abortion Care
    • Drugs in Chronic Kidney Disease: Implications for Pharmacists
    • Medical Devices Training for Pharmacy Technicians

    • Ask the Customer Experience and Administration Team

    • How does the OPA PLI Program compare with other policies?

    • DDD Notice No. 19162 posted November 4, 2019 Prescription Forgery Alert
    • DDD Notice No. 19161 posted November 4, 2019 Prescription Forgery Alert

  • News for the week of October 29, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Towards a sustainable Ontario Drug Benefit Program
    • OPA submission on OCP expanded scope of practice consultation

    • Identifying Drug Interactions
    • Pharmacist Health Coaching – Cardiovascular Program Training Course
    • Interprofessional Relationships and Conflict Management in Primary Care

    • Ask the Practice Support Network
    • Flash Sale: Save 30% Off Dell XPS and Alienware

    • Universal Influenza Immunization Program and Store Insurance
    • Last chance to win a tablet

    • DDD Notice No. 19160 posted October 29, 2019 Prescription Forgery Alert
    • DDD Notice No. 19159 Posted October 29, 2019 Health Network System (HNS) And Narcotics Monitoring System (NMS) Outage Notification to Ontario Drug Programs Agencies
    • DDD Notice No. 19158 posted October 29, 2019 Prescription Forgery Alert
    • DDD Notice No. 19157 posted October 28, 2019 Notice: Proposal to Reduce Administrative Burden to Drug Manufacturers and Pharmacies
    • DDD Notice No. 19156 posted October 28, 2019 Notice: Proposal to Improve the Value of Pharmacy Payments
    • DDD Notice No. 19155 posted October 24, 2019 ODB Formulary – Edition No. 43, Summary of Changes – October 2019
    • DDD Notice No. 19154 posted October 23, 2019 Prescription Forgery Alert

    • Drug Shortage / Supply Health System Alert: Tamoxifen

  • News for the week of October 22, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: 2019-20 Universal Influenza Immunization Program (UIIP) Updates
    • Last week to submit feedback on proposed amendments to expand the scope of practice for pharmacists
    • OPA's Student Advisory Council gets underway
    • McMaster University survey on cannabis

    • FREE - Assessment and Management of Patients with Migraine
    • FREE - Introduction to Caring for Trans Patients in the Pharmacy
    • Selling What You Can Do for Your Clients Program

    • Ask the Customer Experience and Administration Team
    • Spooky Halloween party at Ripley's Aquarium of Canada

    • Store Insurance Risk Prevention
    • Last chance to win a tablet

    • DDD Notice No. 19152 posted October 17, 2019 Prescription Forgery Alert
    • DDD Notice No. 19151 posted October 16, 2019 Notice: Pharmacist administration of publicly funded influenza vaccines and claims submission using the Health Network System

    • Additional ranitidine products recalled, including Zantac; request to stop distribution remains in place while Health Canada continues to assess NDMA

  • News for the week of October 15, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Today was Pharmacy Technician Day!
    • OPP reminder regarding prescription forgeries
    • OPA Student Chapter Executive Teams announced
    • U of T Pharmacy Undergraduate Awards
    • U of T 8T9 Class Reunion

    • Personal Branding for Pharmacy Professionals
    • FREE! An Introduction to Caring for Trans Patients in the Pharmacy
    • An Update on Direct Oral Anticoagulation

    • Ask the Practice Support Network

    • Must-have insurance
    • Win a tablet with the best-in-class coverage

    • Drug Shortage / Supply Health System Alert: SOGC Statement - Oxytocin

    • Some EpiPen and EpiPen Jr auto-injectors may be difficult to remove from their carrier tubes
    • Avalon Fetal Monitor - Risk of Inaccurate Ultrasound-Derived Fetal Heart Rate Monitoring
    • LEMTRADA® (alemtuzumab) – Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions - sanofi-aventis Canada Inc.

Back to top